Beibei Ru
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 3
- Immunology top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 4
- vaccines and immunoinformatics approaches 4
- Glycosylation and Glycoproteins Research 3
- Biochemical and Structural Characterization 3
-
- Monoclonal and Polyclonal Antibodies Research 6
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Beibei Ru
25 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 606
- Pulmonary and Respiratory Medicine 902
- Oncology 631
- Immunology 471
- Molecular Biology 1.5k
Countries citing papers authored by Beibei Ru
This map shows the geographic impact of Beibei Ru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Ru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Ru more than expected).
Fields of papers citing papers by Beibei Ru
This network shows the impact of papers produced by Beibei Ru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Ru. The network helps show where Beibei Ru may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beibei Ru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 47 | |
| 4 | 2021 | 115 | |
| 5 | 2021 | 1 | |
| 6 | TISIDB: an integrated repository portal for tumor–immune system interactionsbreakdown → | 2019 | 1530 |
| 7 | 2018 | 32 | |
| 8 | 2018 | 22 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 28 | |
| 11 | 2017 | 43 | |
| 12 | 2017 | 21 | |
| 13 | 2016 | 40 | |
| 14 | 2016 | 33 | |
| 15 | 2015 | 71 | |
| 16 | 2014 | 15 | |
| 17 | 2013 | 36 | |
| 18 | 2010 | 85 | |
| 19 | 2010 | 46 | |
| 20 | [Metallothionein and cancer]. | 1999 | 1 |
About Beibei Ru
Beibei Ru is a scholar working on Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 25 papers that have together received 2.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Epigenetics and DNA Methylation (4 papers), vaccines and immunoinformatics approaches (4 papers), Glycosylation and Glycoproteins Research (3 papers), MicroRNA in disease regulation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Biochemical and Structural Characterization (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (606 citations), Pulmonary and Respiratory Medicine (902 citations), Oncology (631 citations), Immunology (471 citations) and Molecular Biology (1.5k citations). Beibei Ru has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jiangwen Zhang, Yin Tong, Ching Ngar Wong, Ian Chen, Jia Zhong, Jian Huang, Feng‐Biao Guo, Hao Lin, Shiyong Li and Peng Jiang. Their work appears in journals such as Bioinformatics, Nature Communications, Molecules, Nucleic Acids Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.